ClinicalTrials.govpublic full text
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
acute myeloid leukemia, adult, newly aml diagnosed, npm1, kmt2a, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 829019
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.